# Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation

> **NCT03576716** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 19 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** D6-25-hydroxyvitamin D3

## Key facts

- **NCT ID:** NCT03576716
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2019-07-08
- **Final completion:** 2021-01-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03576716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03576716, "Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03576716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*